Both Novo Nord's Dual GIP/GLP-1 and Wegovy are innovative medications created for treating hyperglycemia and supporting weight loss . However, they work through varied mechanisms . Wegovy is a GLP-1 receptor site agonist , while Novo Nord's Dual check here GIP/GLP-1 acts as a dual GIP and GLP-1 agonist , potentially offering a more significant impa